Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a 15.912% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a CC1(C)CC(=O)c2c(nn(-c3ccccc3)c2-c2ccncc2)C1
b CCOc1ccc2nc(NCCCNS(=O)(=O)c3ccc(Cl)cc3)c(C#N)cc2c1
c Cc1cccc(NC(=S)NNC(=O)c2csc(C(C)C)c2)c1
d NS(=O)(=O)c1ccc2nc(-c3ccccc3)c(-c3ccccc3)nc2c1
e Cc1ccc(-n2c(O)cnc2Nc2nc(C)cc(C)n2)cc1
Answer: b. CCOc1ccc2nc(NCCCNS(=O)(=O)c3ccc(Cl)cc3)c(C#N)cc2c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOc1ccc2nc(NCCCNS(=O)(=O)c3ccc(Cl)cc3)c(C#N)cc2c1
CCOc1ccc2nc(NCCCNS(=O)(=O)c3ccc(Cl)cc3)c(C#N)cc2c1
4-chloro-N-[3-[(3-cyano-6-ethoxyquinolin-2-yl)amino]propyl]benzenesulfonamide